{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Influenza+Virus&page=4", "query": { "condition": "Influenza Virus", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 1004, "total_pages": 101, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Influenza+Virus&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Influenza+Virus&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T18:35:40.355Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06821061", "title": "A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Influenza", "COVID-19 (Coronavirus Disease 2019)" ], "interventions": [ { "name": "Investigational Influenza Vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational COVID-19 Vaccine", "type": "BIOLOGICAL" }, { "name": "Investigational Influenza and COVID-19 Combination Vaccine", "type": "COMBINATION_PRODUCT" }, { "name": "Licensed Influenza Vaccine 1", "type": "BIOLOGICAL" }, { "name": "Licensed Influenza Vaccine 2", "type": "BIOLOGICAL" }, { "name": "Licensed Influenza Vaccine 3", "type": "BIOLOGICAL" }, { "name": "Licensed COVID-19 Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "COMBINATION_PRODUCT" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2650, "start_date": "2025-02-10", "completion_date": "2025-12-17", "has_results": false, "last_update_posted_date": "2026-01-26", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 31, "location_summary": "Anaheim, California • Lake Forest, California • Riverside, California + 26 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Lake Forest", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06821061" }, { "nct_id": "NCT01484522", "title": "Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV-1 Infection", "H1N1", "Influenza", "Flu" ], "interventions": [ { "name": "FluMist", "type": "BIOLOGICAL" }, { "name": "Fluvirin", "type": "BIOLOGICAL" }, { "name": "Fluzone", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "International Maternal Pediatric Adolescent AIDS Clinical Trials Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "25 Years", "sex": "ALL", "summary": "6 Months to 25 Years" }, "enrollment_count": 149, "start_date": "2009-10", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2011-12-02", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01484522" }, { "nct_id": "NCT00836953", "title": "Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Influenza virus vaccine (Pediatric formulation)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "36 Months", "sex": "ALL", "summary": "6 Months to 36 Months" }, "enrollment_count": 33, "start_date": "2003-09", "completion_date": "2004-07", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 1, "location_summary": "Norfolk, Virginia", "locations": [ { "city": "Norfolk", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00836953" }, { "nct_id": "NCT02989194", "title": "Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "VIS410 low dose", "type": "DRUG" }, { "name": "VIS410 high dose", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Visterra, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 150, "start_date": "2017-01-06", "completion_date": "2017-10-27", "has_results": true, "last_update_posted_date": "2022-08-15", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 11, "location_summary": "Huntsville, Alabama • Coral Gables, Florida • Homestead, Florida + 7 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Coral Gables", "state": "Florida" }, { "city": "Homestead", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02989194" }, { "nct_id": "NCT01231620", "title": "A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Influenza, Human" ], "interventions": [ { "name": "Zanamivir", "type": "DRUG" }, { "name": "Placebo to match zanamivir", "type": "DRUG" }, { "name": "Oseltamivir", "type": "DRUG" }, { "name": "Placebo to match oseltamivir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 626, "start_date": "2011-01-15", "completion_date": "2015-03-18", "has_results": true, "last_update_posted_date": "2018-10-15", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Chula Vista, California + 37 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01231620" }, { "nct_id": "NCT04077424", "title": "Senescent Immunity in Elders and Vaccine Responses (SILVER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Flu Vaccine" ], "interventions": [ { "name": "Fluzone-High Dose Quadrivalent", "type": "BIOLOGICAL" }, { "name": "Fluad", "type": "BIOLOGICAL" }, { "name": "Flublock", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": "125 Years", "sex": "ALL", "summary": "65 Years to 125 Years" }, "enrollment_count": 10, "start_date": "2019-10-21", "completion_date": "2020-02-01", "has_results": true, "last_update_posted_date": "2022-07-12", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04077424" }, { "nct_id": "NCT01248520", "title": "Influenza and Text Messaging in Pregnancy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pregnancy" ], "interventions": [ { "name": "influenza and general health information", "type": "OTHER" }, { "name": "general health information", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "14 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "14 Years to 50 Years · Female only" }, "enrollment_count": 216, "start_date": "2010-09", "completion_date": "2014-04", "has_results": false, "last_update_posted_date": "2018-12-13", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01248520" }, { "nct_id": "NCT03300050", "title": "Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Influenza", "Vaccine" ], "interventions": [ { "name": "cH8/1N1 LAIV", "type": "BIOLOGICAL" }, { "name": "AS03-adjuvanted cH5/1N1 IIV", "type": "BIOLOGICAL" }, { "name": "cH5/1N1 IIV", "type": "BIOLOGICAL" }, { "name": "AS03-adjuvanted cH8/1N1 IIV", "type": "BIOLOGICAL" }, { "name": "Normal saline", "type": "BIOLOGICAL" }, { "name": "Phosphate buffered saline (PBS)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "PATH", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 65, "start_date": "2017-10-10", "completion_date": "2019-08-09", "has_results": true, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 2, "location_summary": "Durham, North Carolina • Cincinnati, Ohio", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03300050" }, { "nct_id": "NCT05732610", "title": "MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COVID-19", "Influenza A", "Influenza B" ], "interventions": [ { "name": "MGC Health COVID-19 & Flu A+B Home Multi Test", "type": "DIAGNOSTIC_TEST" }, { "name": "MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Medical Group Care, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 34, "start_date": "2023-02-14", "completion_date": "2023-03-02", "has_results": true, "last_update_posted_date": "2024-05-02", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05732610" }, { "nct_id": "NCT01436370", "title": "TIV and High Dose TIV in Subjects With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Influenza" ], "interventions": [ { "name": "Trivalent inactivated influenza vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 102, "start_date": "2011-10", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-12-24", "last_synced_at": "2026-10-05T18:35:40.355Z", "location_count": 1, "location_summary": "Iowa City, Iowa", "locations": [ { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT01436370" } ] }